Hvad er CVR-nummeret på Antag Therapeutics ApS?

Antag Therapeutics ApS er registreret hos CVR / Virk under CVR 38402056.

Hvad er omsætningen for Antag Therapeutics ApS?

Antag Therapeutics ApS rapporterede en omsætning på DKK -191,6M i 2025.

Antag Therapeutics ApS beskæftiger 9 personer pr. seneste årsrapport.

Philip Just Larsen er administrerende direktør i Antag Therapeutics ApS, i rollen siden 2026.

Keith Richard Leonard Jr er bestyrelsesformand i Antag Therapeutics ApS, i rollen siden 2026.

Antag Therapeutics ApSs registrerede adresse er Ole Maaløes Vej 3.

APSActiveReklamebeskyttelse

CVR 38402056Ole Maaløes Vej 3, 2200 København NManufacture of pharmaceutical preparations· NACE 2120Est. 2017 · 9 years old9 employeeshttp://www.antagtherapeutics.com/

Aktivt ansatte i selskabet

Name	Role	Member since
Current (4)
MB Maria Buur Nordskov Gabe Founder	Founder	2017
JJ Jens Juul Holst Founder	Founder	2017
PJ Philip Just Larsen Chief Executive Officer	Chief Executive Officer	2026
MM Mette Marie Rosenkilde Founder	Founder	2017
Former (2)
JM Jörg Möller Chief Executive Officer	Chief Executive Officer	2025 – 2026
AH Alexander Hovard Sparre-Ulrich Chief Executive Officer	Chief Executive Officer	2017 – 2025

Ikke-udøvende tilsyn

Name	Role	Member since
Current (5)
JS Jørgen Søberg Petersen Board of Directors	Board of Directors	2026
MC Mark Currie Board of Directors	Board of Directors	2023
KR Keith Richard Leonard Jr Chairman	Chairman	2026
AV Alexander Volker Wilhelm Mayweg Board of Directors	Board of Directors	2024
AK Amit Kantilal Shah Board of Directors	Board of Directors	2024
Former (7)
EC Emmanuelle Coutanceau Board of Directors	Board of Directors	2017 – 2020
CT Christine Theresa Fischette Board of Directors	Board of Directors	2021 – 2023
PJ Pieter Jeroen Bakker Board of Directors	Board of Directors	2020 – 2024
JD Jayson Dallas Board of Directors	Board of Directors	2023 – 2023
KA Kirsten Aarup Drejer Chairman	Chairman	2017 – 2023
AG Anker Gunvald Lundemose Board of Directors	Board of Directors	2017 – 2020
TE Thomas Edward Needham Jr. Board of Directors	Board of Directors	2020 – 2023

Pr. seneste årsrapport

Shareholder	Type	Ownership	Votes	Since
Versant Venture Capital VII, L.P.	Individual	25–33.32%	25–33.32%	2026
Novo Holdings A/S	Company	20–24.99%	20–24.99%	2026
Dawn Holdco SCSp	Individual	10–14.99%	10–14.99%	2026
SR One Capital Fund II Aggregator, LP	Individual	5–9.99%	5–9.99%	2026
Danmarks Eksport- og Investeringsfond	Company	5–9.99%	5–9.99%	2023
VÆKSTFONDEN	Company	5–9.99%	5–9.99%	2021
Broadview Ventures I LLC	Individual	5–9.99%	5–9.99%	2021

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.